Triamcinolone acetonide and Multiple sclerosis aggravated - a phase IV clinical study of FDA data

Summary:

Multiple sclerosis aggravated is reported as a side effect among people who take Triamcinolone acetonide (triamcinolone acetonide), especially for people who are female, 50-59 old, also take Lyrica, and have Immune system disorder.

The phase IV clinical study analyzes which people have Multiple sclerosis aggravated when taking Triamcinolone acetonide. It is created by eHealthMe based on reports of 19,460 people who have side effects when taking Triamcinolone acetonide from the FDA, and is updated regularly.

What is Triamcinolone acetonide?

Triamcinolone acetonide has active ingredients of triamcinolone acetonide. It is often used in eczema. eHealthMe is studying from 19,594 Triamcinolone acetonide users. Check the latest studies of Triamcinolone acetonide.

What is Multiple sclerosis aggravated?

Multiple sclerosis aggravated (a nervous system disease that affects your brain and spinal cord. it damages the myelin sheath) is found to be associated with 1,021 drugs and 322 conditions by eHealthMe. Check the latest studies of Multiple sclerosis aggravated.

On Jul, 12, 2026

19,460 people reported to have side effects when taking Triamcinolone acetonide.
Among them, 29 people (0.15%) have Multiple sclerosis aggravated.

Could Triamcinolone acetonide cause Multiple sclerosis aggravated?

Among these 29 people:

What is the gender of people who have Multiple sclerosis aggravated when taking Triamcinolone acetonide? *

female: 62.07 %
male: 37.93 %

What is the age of people who have Multiple sclerosis aggravated when taking Triamcinolone acetonide? *

What are other drugs people take besides Triamcinolone acetonide? *

What are other side effects people have besides Multiple sclerosis aggravated? *

Urinary Tract Infection: 6 people, 20.69%
Hypoaesthesia (reduced sense of touch or sensation): 5 people, 17.24%
Drug Ineffective: 5 people, 17.24%
Gait Disturbance: 5 people, 17.24%
Injection Site Mass: 4 people, 13.79%
Fatigue (feeling of tiredness): 4 people, 13.79%
Paranasal Sinus Discomfort: 4 people, 13.79%
Diarrhea: 4 people, 13.79%
Dermal Cyst: 4 people, 13.79%
Musculoskeletal Stiffness (stiffness of the body's muscles, joints, tendons, ligaments and nerves): 4 people, 13.79%

What are the existing conditions these people have? *

Immune System Disorder: 4 people, 13.79%
Diabetes: 3 people, 10.34%
Hypergammaglobulinaemia (elevated levels of gamma globulin): 3 people, 10.34%
Pain In Extremity: 3 people, 10.34%
Movement Disorder (neurological syndromes where they may be excess of movement or a paucity of movement that is not connected to weakness): 2 people, 6.90%
Weakness: 2 people, 6.90%
Depression: 2 people, 6.90%
Encephalomyelitis (inflammation of the brain and spinal cord): 2 people, 6.90%
Fibromyalgia (a long-term condition which causes pain all over the body): 2 people, 6.90%
Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 2 people, 6.90%

* Approximation only. Some reports may have incomplete information.

Do you take Triamcinolone acetonide and have Multiple sclerosis aggravated?

- Check whether Multiple sclerosis aggravated is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Triamcinolone acetonide:

Triamcinolone acetonide (19,594 reports)

Browse all side effects of Triamcinolone acetonide:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Multiple sclerosis aggravated:

Multiple sclerosis aggravated (1,021 drugs)

Browse all the conditions that are associated with Multiple sclerosis aggravated:

Multiple sclerosis aggravated (322 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on triamcinolone acetonide (the active ingredients of Triamcinolone acetonide) and Triamcinolone acetonide (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.